Article Text
Abstract
While freedom of movement has been one of the most highly respected human right across the EU, there are various aspects which come into play which still need to be resolved for this to be achieved in practice. One of these key issues is cross border health care. Indeed, there is an increasing awareness of standardisation of health service provision and cross border collaboration in the EU. However, certain groups particularly children may be at risk of suboptimal treatment as a result. We present the case of a child patient which highlights the complexity of this matter spanning family law, health law, social security law as well as ethical issues. EU legislation needs to ensure that children patients have access to high quality care across the EU borders.
- Newborns and minors
- quality of health care
- quality/value of life/personhood
Statistics from Altmetric.com
Footnotes
Competing interests None.
Patient consent Obtained.
Provenance and peer review Not commissioned; not externally peer reviewed.
Linked Articles
- Correction
Read the full text or download the PDF:
Other content recommended for you
- Vaccination leads to an aberrant FOXP3 T-cell response in non-remitting juvenile idiopathic arthritis
- Cross-border healthcare in the European Union: clarifying patients’ rights
- Children with extended oligoarticular and polyarticular juvenile idiopathic arthritis have alterations in B and T follicular cell subsets in peripheral blood and a cytokine profile sustaining B cell activation
- Health-related quality of life and disability in adults with juvenile idiopathic arthritis: comparison with adult-onset rheumatic diseases
- Cross-border care and healthcare quality improvement in Europe: the MARQuIS research project
- Synovial membrane immunohistology in early untreated juvenile idiopathic arthritis: differences between clinical subgroups
- Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study
- Therapeutic use of etanercept in polyarticular course juvenile idiopathic arthritis over a two year period
- Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study
- Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis